Unlocking Hope: How Genomics is Shaping Rare Disease Diagnosis & Treatment | M42

Join Kent Rogers, CEO of EveryONE Medicines, Albarah El-khani, Senior Vice President of Operations at M42, Dr. Sharukh Hashmi, Director of Research at the Department of Health Abu Dhabi, Tiago Magalhaes, Vice President of Bioinformatics at M42, and Islam Eltantawy, General Manager at Iros, M42, as they explore how genomics is transforming the diagnosis and treatment of rare diseases. This thought-provoking discussion highlights the power of genomic research and cutting-edge technologies in unlocking hope for patients and families affected by rare conditions. Learn how advancements in bioinformatics and precision medicine are paving the way for more accurate diagnoses and targeted therapies.

Stay informed on the future of rare disease care, subscribe to M42 Health today.

Видео Unlocking Hope: How Genomics is Shaping Rare Disease Diagnosis & Treatment | M42 канала M42 Health